Stock Research: LivaNova

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

LivaNova

NasdaqGS:LIVN GB00BYMT0J19
32
  • Value
    21
  • Growth
    67
  • Safety
    Safety
    51
  • Combined
    34
  • Sentiment
    41
  • 360° View
    360° View
    32
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

LivaNova PLC is a medical technology company. It operates in the medical technology industry, specifically in cardiopulmonary and neuromodulation. LivaNova PLC operates globally. In the last fiscal year, the company had a market cap of $2,368 million, profits of $871 million, revenue of $1,253 million, and 2900 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 32 (better than 32% compared with alternatives), overall professional sentiment and financial characteristics for the stock LivaNova are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for LivaNova. The consolidated Value Rank has an attractive rank of 51, which means that the share price of LivaNova is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 51% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 67, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 41. Professional investors are more confident in 59% other stocks. Worryingly, the company has risky financing, with a Safety rank of 21. This means 79% of comparable companies have a safer financing structure than LivaNova. ...read more

more
Index
NASDAQ
S&P MIDCAP
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
51 30 27 27
Growth
67 26 59 57
Safety
Safety
21 46 54 6
Sentiment
41 56 29 42
360° View
360° View
32 21 27 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
77 85 56 83
Opinions Change
50 56 50 50
Pro Holdings
n/a n/a n/a n/a
Market Pulse
7 25 8 2
Sentiment
41 56 29 42
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
51 30 27 27
Growth
67 26 59 57
Safety Safety
21 46 54 6
Combined
34 9 35 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
81 13 1 20
Price vs. Earnings (P/E)
60 57 56 48
Price vs. Book (P/B)
54 71 68 59
Dividend Yield
1 1 1 1
Value
51 30 27 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
74 37 34 12
Profit Growth
54 55 70 70
Capital Growth
46 34 65 69
Stock Returns
51 30 39 61
Growth
67 26 59 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
46 56 54 36
Refinancing
41 83 73 9
Liquidity
8 12 14 10
Safety Safety
21 46 54 6

Similar Stocks

Discover high‑ranked alternatives to LivaNova and broaden your portfolio horizons.

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Vodafone

LSE:VOD
Country: United Kingdom
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Fresenius

XTRA:FRE
Country: Germany
Industry: Health Care Services
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.